Insulitis in human type 1 diabetes: The quest for an elusive lesion

 Abstract

The histopathology of type 1 diabetes is defined by a decreased β-cell mass in association with insulitis, a characteristic lymphocytic infiltration limited to the islets of Langerhans and prominent in early stage disease in children. A cytotoxic T-cell mediated destruction of insulin-producing β-cells is thought to be initiated by an unknown (auto)antigen, leading to the destruction >75% of β-cell mass at clinical diagnosis. Although considered to be pathognomonic for recent onset disease, insulitis has only been described in approximately 150 cases over the past century. This review describes the quest for this elusive lesion and gives its incidence in various patient subpopulations stratified for age of onset and duration of the disease. It discusses recent new insights into the regenerative capacity of the β-cell mass in the pre-clinical stages of the disease and relates these findings to the inflammatory processes within the islet tissue.

Full Text Options
Article
Metrics
 Share
 Full Text
 Info
Pages
131 - 138
doi
10.4161/isl.3.4.15728
Type
Review
 Metrics
 Cite This Article
 Permissions
 Permissions
 Reprints
Insulitis in human type 1 diabetes: The quest for an elusive lesion